0000000000583100

AUTHOR

Anna Watermann

showing 1 related works from this author

Fluorescein- and EGFR-Antibody Conjugated Silica Nanoparticles for Enhancement of Real-time Tumor Border Definition Using Confocal Laser Endomicrosco…

2019

Intraoperative definition of tumor free resection margins in head and neck cancer is challenging. In the current proof-of-principle study we evaluated a novel silica nanoparticle-based agent for its potential use as contrast enhancer. We synthesized silica nanoparticles with an average size of 45 nm and modified these particles with the fluorescence stain fluorescein isocyanate (FITC) for particle detection and with epidermal growth factor receptor (EGFR)-targeting antibodies for enhanced tumor specificity. The nanoparticles exhibited good biocompatibility and could be detected in vitro and in vivo by confocal laser scanning microscopy. Additionally, we show in an ex vivo setting that these…

biologyBiocompatibilityGeneral Chemical EngineeringConfocalEGFRcontrast agentsilica nanoparticlesStainEGFR AntibodyArticlelcsh:Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistrylcsh:QD1-999In vivo030220 oncology & carcinogenesisbiology.proteinGeneral Materials ScienceEpidermal growth factor receptorFluorescein030223 otorhinolaryngologyEx vivoBiomedical engineeringNanomaterials
researchProduct